Cronos Group (CRON) said Tuesday its wholly-owned subsidiary has agreed to acquire all of the outstanding shares of CanAdelaar, Netherland-based cannabis company.
Under the deal, the companies said it will purchase all the shares of CanAdelaar for up-front consideration of 57.5 million euro ($67 million).
The transaction is expected to close in early 2026, it added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments